CONTINUUS Pharmaceuticals recently completed the opening of a new OEB4 Highly Potent API R&D laboratory earlier this year within 6 months from building occupancy.
This talk will touch on the comprehensive safety programs developed and the cross functional approach used to manage the buildout, focusing on the implementation of the hierarchy of controls.
Risk-based safety procedures, engineering controls equipment, and industrial hygiene practices used in the safe operation of this R&D laboratory will all be discussed.
View Details
